心臓外科　Knack & Pitfalls　心不全外科治療の要点と盲点

出版社： 文光堂
著者：
発行日： 2012-11-15
分野： 臨床医学：外科  >  心臓/血管外科
ISBN： 9784830623349
シリーズ： Knack & Pitfalls
電子書籍版： 2012-11-15 （第1版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

19,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

19,800 円(税込)

購入する

商品紹介

心不全の外科治療は心臓外科において古くて新しい分野である。飛躍的に発展した今日の重症心不全の外科治療の最先端を1冊にまとめた。

目次

  • 心臓外科 Knack & Pitfalls　心不全外科治療の要点と盲点

    ―目次―

    ?．心不全外科治療の現況
    　1．心不全外科治療の現況
    　2．心不全内科薬物治療の現況
    　3．心不全内科非薬物治療の現況

    II．非薬物治療戦略決定のKnack & Pitfalls
    　1．心不全へのカスケード
    　2．心不全治療を分類から考える
    　3．急性心不全の非薬物治療の適応
    　　a．虚血性心疾患を原疾患とする急性心不全
    　　b．弁膜症を原疾患とする急性心不全
    　　c．先天性心疾患を原疾患とする急性心不全
    　4．慢性心不全の外科治療の適応
    　　a．虚血性心筋症を原疾患とする慢性心不全
    　　b．特発性心筋症を原疾患とする慢性心不全
    　　c．劇症型心筋炎を原疾患とする慢性心不全
    　　　　　―機械的補助循環の適応―
    　　d．弁膜症と高血圧による二次性心筋症を原疾患とする
    　　　　　─慢性心不全─

    III．術前管理のKnack & Pitfalls
    　1．心不全の術前管理
    　2．呼吸不全合併症例の術前管理
    　3．腎不全合併症例の術前管理
    　4．肝不全合併症例の術前管理
    　5．その他の合併症の術前管理

    IV．周術期管理のKnack & Pitfalls
    　1．呼吸・循環不全合併症例の周術期管理
    　2．腎不全合併症例の周術期管理
    　3．肝不全合併症例の周術期管理
    　4．糖尿病合併症例の周術期管理
    　5．右心不全症例の周術期管理
    　6．感染対策
    　7．抗血栓・出血対策
    　8．心臓リハビリテーション

    ?．心不全外科のKnack & Pitfalls
    　1．左室形成術
    　2．補助人工心臓
    　　a．種類と特徴
    　　b．植え込み手術の実際とデバイス管理
    　　　1）第2世代植込み型補助人工心臓
    　　　　　（1）EVAHEART
    　　　　　（2）Jarvik2000
    　　　　　（3）HeartMateII
    　　　2）第3世代植込み型補助人工心臓
    　　　　　―DuraHeartとHeartWare HVAD―
    　　　3）ニプロ型VADシステム
    　　　4）体外設置型補助人工心臓―BVS5000，AB5000―
    　　c．補助人工心臓の長期在宅療法―destination therapy―
    　3．心臓移植
    　　a．補助人工心臓ブリッジ症例の心臓移植手術
    　　　1）心臓移植手術の実際
    　　　2）補助人工心臓送脱血管・ドライブライン刺入部の処置
    　　b．急性拒絶反応と術後早期の免疫抑制療法
    　　c．感染対策
    　　d．冠動脈病変の進行防止
    　　e．悪性新生物対策
    　4．再生医療
    　　a．心筋再生のマテリアル
    　　b．心臓再生医療の術中アプローチ法
    　　c．心筋シート臨床治験―術後評価のポイント―
    　　d．補助人工心臓ブリッジ症例の再生医療

    VI．在宅安全管理のKnack & Pitfalls
    　1．薬物治療・右心不全管理
    　2．ドライブライン管理
    　3．デバイス管理・モニタリング
    　4．抗血栓療法

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

[I] 心不全外科治療の現況

P.5 掲載の参考文献
1) Kinugawa, K : How to treat stage D heart failure? -When to implant left ventricular assist devices in the era of continuous flow pumps? Circ J 2011 ; 75 : 2038-2045
 
2) Batista, RJ et al : Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 1996 ; 11 : 96-97 ; discussion 98
 
3) Dor, V et al : Left ventricular aneurysm : a new surgical approach. Thorac Cardiovasc Surg 1989 ; 37 : 11-19
 
4) Franco-Cereceda, A et al : Partial left ventriculectomy for dilated cardiomyopathy : Is this an alternative to transplantation? J Thorac Cardiovasc Surg 2001 ; 121 : 879-893
 
5) Isomura, T et al : Left ventricle restoration in patients with non-ischemic dilated cardiomyopathy : risk factors and predictors of outcome and change of mid-term ventricular function. Eur J Cardiothorac Surg 2001 ; 19 : 684-689
 
6) Jones, RH et al : Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009 ; 360 : 1705-1717
 
7) Rose, EA et al : Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001 ; 345 : 1435-1443
 
8) Slaughter, MS et al : Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009 ; 361 : 2241-2251
 
P.10 掲載の参考文献
1) 松崎益徳ほか : 慢性心不全治療ガイドライン (2010年改訂版), 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2010_matsuzaki_h.pdf (2012年9月閲覧)
 
2) Packer, M et al : The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996 ; 334 : 1349-1355
 
3) Packer, M et al : Effect of carvedilol on the morbidity of patients with severe chronic heart failure : results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study. Circulation 2002 ; 106 : 2194-2199
 
4) Bristow, MR et al : Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996 ; 94 : 2807-2816
 
5) Packer, M et al : Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999 ; 100 : 2312-2318
 
6) Konstam, MA et al : Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study) : a randomised, double-blind trial. Lancet 2009 ; 374 : 1840-1848
 
7) Willenheimer, R et al : Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence : results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 2005 ; 112 : 2426-2435
 
8) Guder, G et al : Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 2007 ; 115 : 1754-1761
 
9) Pitt, B et al : The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999 ; 341 : 709-717
 
10) Zannad, F et al : Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011 ; 364 : 11-21
PubMed
11) Konstam, MA et al : Effects of oral tolvaptan in patients hospitalized for worsening heart failure : the EVEREST outcome trial. JAMA 2007 ; 297 : 1319-1331
 
12) Gheorghiade, M et al : Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure : the EVEREST clinical status trials. JAMA 2007 ; 297 : 1332-1343
 
13) The Digitalis Investigation Group : The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997 ; 336 : 525-533
 
14) Effects of Pimobendan on Chronic Heart Failure Study (EPOCH Study) : Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure : the effects of pimobendan on chronic heart failure study (EPOCH study). Circ J 2002 ; 66 : 149-157
 
15) McMurray, JJV et al : Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circ Heart Fail 2008 ; 1 : 17-24
 
16) Swedberg, K et al : Ivabradine and outcomes in chronic heart failure (SHIFT) : a randomised placebo-controlled study. Lancet 2010 ; 376 : 875-885
 
P.15 掲載の参考文献
1) Cleland, JG et al : The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 ; 352 : 1539-1549
 
2) Bristow, MR et al : Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 ; 350 : 2140-2150
 
3) 奥村謙ほか : 不整脈の非薬物治療ガイドライン (2011年改訂版), 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf (2012年9月閲覧)
 
4) Auricchio, A et al : Non-responders to cardiac resynchronization therapy : the magnitude of the problem and the issues. Circ J 2011 ; 75 : 521-527
 
5) Cleland, J et al : Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol 2008 ; 52 : 438-445
 
6) Chung, ES et al : Results of the predictors of response to CRT (PROSPECT) trial. Circulation 2008 ; 117 : 2608-2616
 
7) Moss, AJ et al : Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009 ; 361 : 1329-1338
 
8) Vidal, B et al : Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure. Eur J Heart Fail 2010 ; 12 : 283-287
 
9) Ypenburg, C et al : Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009 ; 53 : 483-490
 
10) Nomura, F et al : Efficacy of left ventricular restoration with mitral valve surgery for endstage ischemic cardiomyopathy. Interact Cardiovasc Thorac Surg 2006 ; 5 : 179-182
 
11) Suma, H et al : Selected ventriculoplasty for idiopathic dilated cardiomyopathy with advanced congestive heart failure : midterm results and risk analysis. Eur J Cardiothorac Surg 2007 ; 32 : 912-916
 

[II] 非薬物治療戦略決定のKnack & Pitfalls

P.21 掲載の参考文献
1) Cohn, JN et al : Cardiac remodeling-concepts and clinical implications : a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000 ; 35 : 569-582
 
2) Mann, DL : Mechanisms and models in heart failure : a combinatorial approach. Circulation 1999 ; 100 : 999-1008
 
3) 甲斐久史 : リモデリング, 心不全の発症進展機序, 慢性心不全治療の進歩-成因と臨床研究-. 日本臨牀 2006 ; 64 : 855-860
 
4) 葭山稔 : レニン- アンジオテンシン-アルドステロン系と心臓リモデリング, 心臓リモデリング治療へのあらたな展開, 心不全UPDATE, 心不全発症の分子メカニズム. 医学のあゆみ 2006 ; 218 : 1111-1116
 
5) Mitchell, GF et al : Left ventricular remodeling in the year after first anterior myocardial infarction : a quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol 1992 ; 19 : 1136-1144
 
6) Lamas, GA et al : Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation 1997 ; 96 : 827-833
 
7) 尾辻豊ほか : 虚血性僧帽弁逆流 : 予後と機序, 僧帽弁逆流の心エコー-ゴールド・スタンダードとしての役割-. 心エコー 2004 ; 5 : 778-783
 
8) Otsuji, Y et al : Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation : direct in vivo demonstration of altered leaflet tethering geometry. Circulation 1997 ; 96 : 1999-2008
 
9) Yiu, SF et al : Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction : a quantitative clinical study. Circulation 2000 ; 102 : 1400-1406
 
P.26 掲載の参考文献
1) The Criteria Committee of the New York Heart Association. Diseases of the Heart and Blood Vessels. Nomenclature and Criteria of Diagnosis. 6 th ed, Little, Brown, Boston, 1964
 
2) 松崎益徳ほか : 慢性心不全治療ガイドライン (2010年改訂版), 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2010_matsuzaki_h.pdf (2012年9月閲覧)
 
3) Jessup, M et al : 2009 Focused Update : ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 2009 ; 119 : 1977-2016
 
4) Kinugawa, K : How to treat stage D heart failure? -When to implant left ventricular assist devices in the era of continuous flow pumps? -. Circ J 2011 ; 75 : 2038-2045
 
5) Stevenson, LW et al : INTERMACS profiles of advanced heart failure : the current picture. J Heart Lung Transplant 2009 ; 28 : 535-541
 
P.32 掲載の参考文献
1) Wright, RS et al : 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline) : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011 ; 57 : 1920-1959
 
2) Antman, EM et al : 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008 ; 51 : 210-247
 
3) Kolh, P et al : Guidelines on myocardial revascularization. Eur J Cardiothorac Surg 2010 ; 38 : S 1-S 52
 
4) 藤原久義ほか : 安定冠動脈疾患における待機的PCIのガイドライン (2011年改訂版), 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2011_fujiwara_h.pdf (2012年9月閲覧)
 
5) Fox, KA et al : Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol 2010 ; 55 : 2435-2445
 
6) Keeley, EC et al : Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials. Lancet 2003 ; 361 : 13-20
 
7) Kalla, K et al : Implementation of guidelines improves the standard of care : The Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry). Circulation 2006 ; 113 : 2398-2405
 
8) Zahn, R et al : Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). J Am Coll Cardiol 2000 ; 36 : 2064-2071
PubMed
9) Smith, SC, Jr et al : ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006 ; 113 : e 166-e 286
 
10) Weiss, ES et al : Optimal timing of coronary artery bypass after acute myocardial infarction : A review of California discharge data. J Thorac Cardiovasc Surg 2008 ; 135 : 503-511
 
11) Arnaoutakis, GJ et al : Surgical repair of ventricular septal defect after myocardial infarction : Outcomes From The Society of Thoracic Surgeons National Database. Ann Thorac Surg 2012 ; 94 : 436-444
 
12) Komeda, M et al : Surgical repair of postinfarction ventricular septal defect. Circulation 1990 ; 82 (5 Suppl) : IV 243-IV 247
 
13) David, TE et al : Surgical repair of postinfarction ventricular septal defect by infarct exclusion. Semin Thorac Cardiovasc Surg 1998 ; 10 : 105-110
 
14) Madsen, JC et al : Repair of postinfarction ventricular septal defects. Semin Thorac Cardiovasc Surg 1998 ; 10 : 117-127
 
15) Isoda, S et al : Sandwich technique via right ventricle incision to repair postinfarction ventricular septal defect. J Card Surg 2004 ; 19 : 149-150
 
16) Agnihotri, AK et al : Surgical treatment of complications of acute myocardial infarction : postinfarction ventricular septal defect and free wall rupture, Chapter 28, Cardiac Surgery in the Adult, 4 th ed, Cohn LH ed, McGraw Hill, New York, 2012, 603-607
 
17) Lee, MS et al : Intraoperative device closure of postinfarction ventricular septal defects. Ann Thorac Surg 2010 ; 89 : e 48-e 50
 
18) Love, BA et al : Perventricular device closure of post-myocardial infarction ventricular septal defect on the beating heart. J Thorac Cardiovasc Surg 2011 ; 142 : 230-232
 
19) Atluri, P et al : Ischemic mitral regurgitation, Chapter 29, Cardiac Surgery in the Adult, 4 th ed, Cohn LH ed, McGraw Hill, New York, 2012, 629-662
 
20) Russo, A et al : Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. Circulation 2008 ; 118 : 1528-1534
 
P.38 掲載の参考文献
1) Movsowitz, HD et al : Transesophageal echocardiographic description of the mechanisms of aortic regurgitation in acute type A aortic dissection : implications for aortic valve repair. J Am Coll Cardiol 2000 ; 36 : 884-890
 
2) Bonow, RO et al : 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease : A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) : Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008 ; 118 : e 523-e 661
 
3) Lokhandwala, YY et al : Emergent balloon mitral valvotomy in patients presenting with cardiac arrest, cardiogenic shock or refractory pulmonary edema. J Am Coll Cardiol 1998 ; 32 : 154-158
PubMed
P.52 掲載の参考文献
1) Braun, J et al : Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg 2008 ; 85 : 430-437
 
2) Wu, AH et al : Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005 ; 45 : 381-387
 
3) Toda, K et al : Impact of preoperative percutaneous cardiopulmonary support on outcome following left ventricular assist device implantation. Circ J 2012 ; 76 : 88-95
 
4) Matsumiya, G et al : Myocardial recovery by mechanical unloading with left ventricular assist system. Circ J 2009 ; 73 : 1386-1392
 
P.57 掲載の参考文献
1) McCarthy, RE 3 rd et al : Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000 ; 342 : 690-695
 
2) 和泉徹ほか : 急性および慢性心筋炎の診断・治療に関するガイドライン (2009年改訂版), 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2009_izumi_h.pdf (2012年9月閲覧)
 
3) Aoyama, N et al : National survey of fulminant myocarditis in Japan : therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J 2002 ; 66 : 133-144
 
4) Nishii, M et al : Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol 2004 ; 44 : 1292-1297
 
P.62 掲載の参考文献
1) 中村憲司 : 心臓超音波診断アトラス 成人編, 改訂版, ベクトル・コア, 東京, 2008
 
2) Bonow, RO et al : ACC/AHA 2006 guidelines for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) : Developed in Collaboration With the Society of Cardiovascular Anesthesiologists : Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006 ; 114 : e 84-e 231
 
3) Leon, MB et al : Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010 ; 363 : 1597-1607
 
4) Carabello, BA et al : Predictors of outcome for aortic valve replacement in patients with aortic regurgitation and left ventricular dysfunction : a change in the measuring stick. J Am Coll Cardiol 1987 ; 10 : 991-997
 
5) Stulak, JM et al : Does early surgical intervention improve left ventricular mass regression after mitral valve repair for leaflet prolapse? J Thorac Cardiovasc Surg 2011 ; 141 : 122-129
 
P.64 掲載の参考文献
1) Swain, SM et al : Congestive heart failure in patients treated with doxorubicin : a retrospective analysis of three trials. Cancer 2003 ; 97 : 2869-2879
 
P.66 掲載の参考文献
1) Demakis, JG et al : Natural course of peripartum cardiomyopathy. Circulation 1971 ; 44 : 1053-1061
 
2) Kamiya, CA et al : Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy-. Circ J 2011 ; 75 : 1975-1981
 
3) Hilfiker-Kleiner, D et al : A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007 ; 128 : 589-600
 
4) Patten, IS et al : Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012 ; 485 : 333-338
 
P.68 掲載の参考文献
1) Sekhri, V et al : Cardiac sarcoidosis : a comprehensive review. Arch Med Sci 2011 ; 7 : 546-554
 
2) Kim, JS et al : Cardiac sarcoidosis. Am Heart J 2009 ; 157 : 9-21
 
3) Roberts, WC et al : Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure. Am J Cardiol 2009 ; 103 : 110-114
 
4) Milman, N et al : Cardiac sarcoidosis and heart transplantation : a report of four consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis 2008 ; 25 : 51-59
 
5) Chang, TI et al : Isolated cardiac sarcoidosis in heart transplantation. Transplant Proc 2012 ; 44 : 903-906
 
6) Zaidi, AR et al : Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant 2007 ; 26 : 714-717
 

[III] 術前管理のKnack & Pitfalls

P.74 掲載の参考文献
1) Rose, EA et al : Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001 ; 345 : 1435-1443
 
2) Kirklin, JK et al : Second INTERMACS Annual Report : more than 1, 000 primary left ventricular assist device implants. J Heart Lung Transplant 2010 ; 29 : 1-10
 
3) 松崎益徳ほか : 慢性心不全治療ガイドライン (2010年改訂版), 循環器病の診断と治療に関するガイドライン (2009 年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2010_matsuzaki_h.pdf (2012年9月閲覧)
 
4) The EPOCH Study Group : Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure : the effects of pimobendan on chronic heart failure study (EPOCH study). Circ J 2002 ; 66 : 149-157
 
5) Shiga, T et al : Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation. Circ J 2011 ; 75 : 121-128
 
6) Kinugawa, K : How to treat stage D heart failure? -When to implant left ventricular assist devices in the era of continuous flow pumps? -. Circ J 2011 ; 75 : 2038-2045
 
P.82 掲載の参考文献
1) Misra, A et al : Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008 ; 93 : S 9-S 30
 
2) Ronco, C et al : Cardiorenal syndrome. J Am Coll Cardiol 2008 ; 52 : 1527-1539
 
3) Tonelli, M et al : Chronic kidney disease and mortality risk : a systematic review. J Am Soc Nephrol 2006 ; 17 : 2034-2047
 
4) Foley, RN et al : Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998 ; 32 : S 112-S 119
 
5) Go, AS et al : Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 ; 351 : 1296-1305
 
6) Manjunath, G et al : Estimating the glomerular filtration rate. Dos and don'ts for assessing kidney function. Postgrad Med 2001 ; 110 : 55-62 ; quiz 11
 
7) Matsuo, S et al : Current status of estimated glomerular filtration rate (eGFR) equations for Asians and an approach to create a common eGFR equation. Nephrology (Carlton) 2010 ; 15 Suppl 2 : 45-48
 
8) Huang, TM et al : Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting. J Am Soc Nephrol 2011 ; 22 : 156-163
 
9) McCullough, PA et al : The deadly triangle of anemia, renal insufficiency, and cardiovascular disease : implications for prognosis and treatment. Rev Cardiovasc Med 2005 ; 6 : 1-10
PubMed
10) Weir, MR et al : Acute kidney injury following cardiac surgery : role of perioperative blood pressure control. Am J Nephrol 2011 ; 33 : 438-452
 
11) Pigott, DW et al : Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth 1999 ; 83 : 715-720
 
12) Chirumamilla, AP et al : Outcome of renal insufficiency patients undergoing coronary artery bypass graft surgery. Cardiology 2008 ; 111 : 23-29
 
13) Provatopoulou, ST et al : Clinical use of erythropoietin in chronic kidney disease : outcomes and future prospects. Hippokratia 2011 ; 15 : 109-115
 
14) Parfrey, PS : Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure. Curr Opin Nephrol Hypertens 2011 ; 20 : 177-181
 
15) Inrig, JK et al : Effect of hemoglobin target on progression of kidney disease : A secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) Trial. Am J Kidney Dis 2012 ; 60 : 390-401
 
16) Sezai, A et al : Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting : the NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery) trial for CKD. J Am Coll Cardiol 2011 ; 58 : 897-903
 
17) Okada, H et al : Does intensive perioperative dialysis improve the results of coronary artery bypass grafting in haemodialysed patients? Nephrol Dial Transplant 1999 ; 14 : 771-775
 
P.86 掲載の参考文献
1) Chokshi, A et al : Hepatic dysfunction and survival after orthotopic heart transplantation : application of the MELD scoring system for outcome prediction. J Heart Lung Transplant 2012 ; 31 : 591-600
 
2) United Network for Organ Sharing : MELD/PELD Calculator Documentation, http://www.unos.org/docs/MELD_PELD_Calculator_Documentation.pdf. Accessted June 23, 2012
 
3) Yang, JA et al : Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support : Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant 2012 ; 31 : 601-610
 
4) Morita, S et al : Right ventricular/arterial coupling in the patient with left ventricular assistance. Circulation 1992 ; 86 (5 Suppl) : II 316-II 325
 
5) Kavarana, MN et al : Right ventricular dysfunction and organ failure in left ventricular assist device recipients : a continuing problem. Ann Thorac Surg 2002 ; 73 : 745-750
 
P.91 掲載の参考文献
1) 中野赳ほか : 肺高血圧症治療ガイドライン (2006年改訂版), 循環器病の診断と治療に関するガイドライン (2005年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2006_nakano_h.pdf (2012年9月閲覧)
 
2) Mikus, E et al : Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. Eur J Cardiothorac Surg 2011 ; 40 : 971-977
 
3) Matthews, JC et al : The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008 ; 51 : 2163-2172
 
4) Anker, SD et al : The syndrome of cardiac cachexia. Int J Cardiol 2002 ; 85 : 51-66
 
5) Passantino, A et al : Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice. J Am Coll Cardiol 2006 ; 48 : 99-105
 

[IV] 周術期管理のKnack & Pitfalls

P.100 掲載の参考文献
1) Hisatomi, K et al : Multicenter trial of carperitide in patients with renal dysfunction undergoing cardiovascular surgery. Gen Thorac Cardiovasc Surg 2012 ; 60 : 21-30
 
2) 尾上雅彦ほか : 小児心臓手術におけるmodified ultrafiltrationのピットフォール. 胸部外科 2002 ; 55 : 556-560
 
3) 山村光弘ほか : 慢性血液透析症例の開心術における術後早期持続血液透析濾過 (CHDF) の有用性. 日心臓血管外会誌 2010 ; 39 : 300-304
 
4) Nishimura, M et al : Importance of luxury flow for critically ill patients receiving a left ventricular assist system. J Artif Organs 2006 ; 9 : 209-213
 
5) 西村隆 : 補助人工心臓の術後管理と合併症対策. 医学のあゆみ 2011 ; 239 : 209-212
 
P.105 掲載の参考文献
1) Fujita, Y et al : Postoperative hyperbilirubinemia after implantation of left ventricular assist device is associated with poor postoperative liver perfusion. J Artif Organs 2005 ; 8 : 28-33
 
2) Bizouarn, P et al : Early and late outcome after elective cardiac surgery in patients with cirrhosis. Ann Thorac Surg 1999 ; 67 : 1334-1338
 
3) Klemperer, JD et al : Cardiac operations in patients with cirrhosis. Ann Thorac Surg 1998 ; 65 : 85-87
 
4) Filsoufi, F et al : Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl 2007 ; 13 : 990-995
 
5) Sherlock, S : The liver in heart failure relation of anatomical, functional, and circulatory changes. Heart 1951 ; 13 : 273-293
 
6) Allen, LA et al : Liver function abnormalities and outcome in patients with chronic heart failure : data from the Candesartan in Heart Failure : Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 2009 ; 11 : 170-177
 
7) Nishimura, M et al : Importance of luxury flow for critically ill patients receiving a left ventricular assist system. J Artif Organs 2006 ; 9 : 209-213
 
P.109 掲載の参考文献
1) Wiener, RS et al : Benefits and risks of tight glucose control in critically ill adults : a meta-analysis. JAMA 2008 ; 300 : 933-944
 
2) Finfer, S et al : Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009 ; 360 : 1283-1297
 
3) Lazar, HL et al : The Society of Thoracic Surgeons practice guideline series : Blood glucose management during adult cardiac surgery. Ann Thorac Surg 2009 ; 87 : 663-669
 
4) Kirklin, JK et al : The Fourth INTERMACS Annual Report : 4, 000 implants and counting. J Heart Lung Transplant 2012 ; 31 : 117-126
 
5) Kirklin, JK et al : Third INTERMACS Annual Report : the evolution of destination therapy in the United States. J Heart Lung Transplant 2011 ; 30 : 115-123
 
6) Costanzo, MR et al : The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010 ; 29 : 914-956
 
P.114 掲載の参考文献
1) Nishimura, M et al : Importance of luxury flow for critically ill patients receiving a left ventricular assist system. J Artif Organs 2006 ; 9 : 209-213
 
2) Kirklin, JK et al : The Fourth INTERMACS Annual Report : 4, 000 implants and counting. J Heart Lung Transplant 2012 ; 31 : 117-126
 
3) Cleveland, JC Jr et al : Survival after biventricular assist device implantation : an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database. J Heart Lung Transplant 2011 ; 30 : 862-869
 
4) Shiga, T et al : Combination evaluation of preoperative risk indices predicts requirement of biventricular assist device. Circ J 2012 (in press)
 
5) Saito, S et al : Risk factor analysis of long-term support with left ventricular assist system. Circ J 2010 ; 74 : 715-722
 
6) Fukamachi, K et al : Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 1999 ; 68 : 2181-2184
 
7) Santambrogio, L et al : Right ventricular failure after left ventricular assist device insertion : preoperative risk factors. Interact CardioVasc Thorac Surg 2006 ; 5 : 379-382
 
8) Saito, S et al : Recovery of right heart function with temporary right ventricular assist using a centrifugal pump in patients with severe biventricular failure. J Heart Lung Transplant 2012 ; 31 : 858-864
 
9) Gojo, S et al : Successful LVAS and RVAS-ECMO support in a patient with fulminant myocarditis who failed to recover from ventricular fibrillation with PCPS and IABP. J Thorac Cardiovasc Surg 2003 ; 126 : 885-886
 
10) Kurihara, C et al : Prolonged biventricular assist device support as a bridge to heart transplantation. J Artif Organs 2011 ; 14 : 367-370
 
11) Potapov, E et al : Discontinuation of HeartWare RVAD support without device removal in chronic BIVAD patients. ASAIO J 2012 ; 58 : 15-18
 
12) Saito, S et al : Biventricular support using implantable continuous-flow ventricular assist devices. J Heart Lung Transplant 2011 ; 30 : 475-478
 
P.119 掲載の参考文献
1) 竹末芳生ほか : 抗菌薬の適正使用 : 米国と日本の考え方の違い. 日外会誌 2004 ; 105 : 709-715
 
2) 田ノ上禎久 : 4. 感染予防と治療, Part V. 心臓移植待機中の管理, 心臓移植, シュプリンガー・ジャパン, 東京, 140-142, 2011
 
3) 許俊鋭ほか : 心大血管術後縦隔洞炎のアウトカム-特に重症心不全に対する補助人工心臓治療での経験-. 形成外科 2011 ; 54 : 1329-1334
 
4) Saito, S et al : Fifteen-year experience with Toyobo paracorporeal left ventricular assist system. J Artif Organs 2009 ; 12 : 27-34
 
5) Kawata, M et al : Negative pressure wound therapy for left ventricular assist device-related mediastinitis : two case reports. J Artif Organs 2011 ; 14 : 159-162
 
P.122 掲載の参考文献
1) Lip, GYH et al : Thrombo-embolism and anti-thrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Eur J Heart Fail 2012 ; 14 : 681-695
 
2) Cohn, W et al : Staged reoperation : a novel strategy for high-risk patients. Ann Thorac Surg 2007 ; 83 : 1558-1559
 
3) Malehsa, D et al : Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Eur J Cardiothorac Surg 2009 ; 35 : 1091-1093
 
4) Kormos, RL et al : Adverse events and complications of mechanical circulatory support. Mechanical circulatory support, Elsevier, Philadelphia, 2012, 165-182
 
P.130 掲載の参考文献
1) 野原隆司ほか : 心血管疾患におけるリハビリテーションに関するガイドライン (2007年改訂版), 循環器病の診断と治療に関するガイドライン (2006年度合同研究班報告). ホームページ公開のみ, http://www.j-circ.or.jp/guideline/pdf/JCS2007_nohara_h.pdf (2012年9月閲覧)
 
P.131 掲載の参考文献
1) Clauss, RH et al : Assisted circulation. I. The arterial counterpulsator. J Thorac Cardiovasc Surg 1961 ; 41 : 447-458
 
2) Lawson, WE et al : Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol 1992 ; 70 : 859-862
 
3) Shimizu, T et al : Effect of external counterpulsation on cardiac work following cardiac surgery : implications of the mechanism responsible for clinical benefits. J Cardiol 2012 ; 59 : 84-90
 
4) Giridharan, GA et al : Counterpulsation with symphony prevents retrograde carotid, aortic, and coronary flows observed with intra-aortic balloon pump support. Artif Organs 2012 ; 36 : 600-606
 

[V] 心不全外科治療のKnack & Pitfalls

P.139 掲載の参考文献
1) Dor, V et al : Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction : comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 1998 ; 116 : 50-59
 
2) Isomura, T et al : Septal anterior ventricular exclusion operation (Pacopexy) for ischemic dilated cardiomyopathy : treat form not disease. Eur J Cardiothorac Surg 2006 ; 29 : S 245-S 250
PubMed
3) Matsui, Y : Overlapping left ventricular restoration. Circ J 2009 ; 73 Suppl A : A 13-A 18
 
4) Frater, RW : The effects on cordal and leaflet stiffness of severe apical, posterior, and outward papillary displacement in advanced ventricular mechanism heart failure and mitral insufficiency. J Heart Valve Dis 2011 ; 20 : 608-618
 
5) Jones, RH et al : Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009 ; 360 : 1705-1717
 
P.144 掲載の参考文献
1) Joyce, LD et al : Response of the human body to the first permanent implant of the Jarvik-7 Total Artificial Heart. Trans Am Soc Artif Intern Organs 1983 ; 29 : 81-87
 
2) Dowling, RD et al : Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 2004 ; 127 : 131-141
 
3) Rose, EA et al : Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001 ; 345 : 1435-1443
 
4) Slaughter, MS et al : Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009 ; 361 : 2241-2251
 
5) Matsuwaka, R et al : Overseas transport of a patient with an extracorporeal left ventricular assist device. Ann Thorac Surg 1995 ; 59 : 522-523
 
6) Kyo, S et al : Prognosis of dilative cardiomyopathy and bridge use of left ventricular assist device to heart transplantation. Jpn J Cardiovas Surg 1993 ; 22 (suppl) : 255 (in Japanese)
 
7) 許俊鋭 : 埋め込み型LVASの臨床導入 : ノバコア保険償還の経緯と今後の課題. Cardiovascular Med-Surg 2005 ; 7 : 279-283
 
P.145 掲載の参考文献
1) Kawashima, D et al : Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J 2011 ; 57 : 169-176
 
2) Remmelink, M et al : Effects of left ventricular unloading by Impella recover LP 2.5 on coronary hemodynamics. Catheter Cardiovasc Interv 2007 ; 70 : 532-537
 
P.147 掲載の参考文献
1) John, R et al : Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 2007 ; 134 : 351-358
 
2) De Robertis, F et al : Bridge to decision using the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant 2008 ; 27 : 474-478
 
P.152 掲載の参考文献
1) Yamazaki, K et al : Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump : mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg 2007 ; 55 : 158-162
 
2) Yamazaki, K et al : EVAHEART : an implantable centrifugal blood pump for long-term circulatory support. Jpn J Thorac Cardiovasc Surg 2002 ; 50 : 461-465
 
3) Yamazaki, K et al : An implantable centrifugal blood pump with a recirculating purge system (Cool-Seal system). Artif Organs 1998 ; 22 : 466-474
 
P.157 掲載の参考文献
1) Westaby, S et al : Implant technique for the Jarvik 2000 heart. Ann Thorac Surg 2002 ; 73 : 1337-1340
 
2) Frazier, OH et al : Initial experience with non-thoracic, extraperitoneal, off-pump insertion of the Jarvik 2000 Heart in patients with previous median sternotomy. J Heart Lung Transplant 2006 ; 25 : 499-503
 
3) Tuzun, E et al : The effect of intermittent low speed mode upon aortic valve opening in calves supported with a Jarvik 2000 axial flow device. ASAIO J 2005 ; 51 : 139-143
 
4) Haj-Yahia, S et al : Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg 2007 ; 134 : 199-203
 
P.163 掲載の参考文献
1) Thoratec 社ホームページ (http://www.thoratec.com/)
 
2) Rose, EA et al : Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001 ; 345 : 1435-1443
 
3) Griffith, BP et al : HeartMate II left ventricular assist system : from concept to first clinical use. Ann Thorac Surg 2001 ; 71 : S 116-S 120
 
4) Frazier, OH et al : First clinical use of the redesigned HeartMate II left ventricular assist system in the United States : a case report. Tex Heart Inst J 2004 ; 31 : 157-159
 
5) Miller, LW et al : Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007 ; 357 : 885-896
 
6) Pagani, FD et al : Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009 ; 54 : 312-321
 
7) Starling, RC et al : Results of the post-U. S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation : a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011 ; 57 : 1890-1898
 
8) Park, SJ et al : Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 2012 ; 5 : 241-248
 
9) Slaughter, MS et al : Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009 ; 361 : 2241-2251
 
10) Rogers, JG et al : Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010 ; 55 : 1826-1834
 
P.173 掲載の参考文献
1) Nojiir, C et al : Terumo implantable left ventricular assist system : results of long-term animal study. ASAIO J 2000 ; 46 : 117-122
 
2) Nishinaka, T et al : The DuraHeart VAD, a magnetically levitated centrifugal pump : the University of Vienna bridge-to-transplant experience. Circ J 2006 ; 70 : 1421-1425
 
3) Morshuis, M et al : European experience of Dura-Heart magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg 2009 ; 35 : 1020-1028
 
4) Yoshioka, D et al : Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device. Circ J 2012 ; 76 : 372-376
 
5) Saito, S et al : Biventricular support using implantable continuous-flow ventricular assist devices. J Heart Lung Transplant 2011 ; 30 : 475-478
 
6) Strueber, M et al : Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 2011 ; 57 : 1375-1382
 
7) Aaronson, KD et al : Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012 ; 125 : 3191-3200
 
8) Miera, O et al : First experiences with the Heart-Ware ventricular assist system in children. Ann Thorac Surg 2011 ; 91 : 1256-1260
 
9) Krabatsch, T et al : Biventricular circulatory support with two miniaturized implantable assist devices. Circulation 2011 ; 124 : S 179-S 186
 
P.179 掲載の参考文献
1) 中谷武嗣 : わが国における人工心臓の現状と将来展望. 心臓 2006 ; 38 : 579-584
 
2) 中谷武嗣 : 人工心臓. 重症心不全の予防と治療, 北風政史編, 中外医学社, 東京, 2009, 293-298
 
3) 西岡宏ほか : VAD (VAS) 原理・効果, 機器の操作, 導入方法, 初期設定. 重症集中ケア 2011 ; 11 : 57-65
 
P.184 掲載の参考文献
1) Berlin Heart 社ホームページ : http://www.berlinheart.de/index.php/home
 
2) Hetzer, R et al : Single-center experience with treatment of cardiogenic shock in children by pediatric ventricular assist devices. J Thorac Cardiovasc Surg 2011 ; 141 : 616-623
 
3) Morales, DLS et al : Bridging children of all sizes to cardiac transplantation : The initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant 2011 ; 30 : 1-8
 
4) Almond, CS et al : Abstract 11366, AHA Scientific Session, 2011
 
P.189 掲載の参考文献
1) Joyce, LD et al : Response of the human body to the first permanent implant of the Jarvik-7 total artificial heart. Trans Am Soc Artif Intern Organs 1983 ; 29 : 81-87
 
2) Dowling, RD et al : Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 2004 ; 127 : 131-141
 
3) Rose, EA et al : Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001 ; 345 : 1435-1443
 
4) Slaughter, MS et al : Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009 ; 361 : 2241-2251
 
5) Kirklin, JK et al : The Fourth INTERMACS Annual Report : 4, 000 implants and counting. J Heart Lung Transplant 2012 ; 31 : 117-126
 
6) http://messages.finance.yahoo.com/Stocks(A_to_Z)/Stocks_H/threadview?m=tm&bn=93087&tid=841&mid=841&tof=40&off=1
 
7) http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM 302187.pdf
 
8) http://pennstatehershey.org/web/lionheart/home
 
P.194 掲載の参考文献
1) Kawata, M et al : Negative pressure wound therapy for left ventricular assist device-related mediastinitis : two case reports. J Artif Organs 2011 ; 14 : 159-162
 
2) 木下修ほか : 心臓移植時の補助人工心臓離脱創に対する局所陰圧閉鎖療法. 日心臓血管外会誌 2012 ; 41 (Suppl) : 418
 
3) 小野稔 : 心臓移植待機患者の課題 : 補助人工心臓装着患者について. 移植 2011 ; 46 : 256-262
 
4) Hisagi, M et al : New pre-clotting method for fibrin glue in a non-sealed graft used in an LVAD : the KYO method. J Artif Organs 2010 ; 13 : 174-177
 
5) Kitamura, S et al : Modification of bicaval anastomosis technique for orthotopic heart transplantation. Ann Thorac Surg 2001 ; 72 : 1405-1406
 
P.198 掲載の参考文献
1) Holman, WL et al : Infection in ventricular assist devices : prevention and treatment. Ann Thorac Surg 2003 ; 75 : S 48-S 57
 
2) McNulty, AK et al : Effects of negative pressure wound therapy on fibroblast viability, chemotactic signaling, and proliferation in a provisional wound (fibrin) matrix. Wound Repair Regen 2007 ; 15 : 838-846
 
P.203 掲載の参考文献
1) McCarthy, PM et al : Heart and heart-lung transplantation : the Stanford experience. Clin Transpl 1989 ; 63-71
 
2) Stehlik, J et al : The Registry of the International Society for Heart and Lung Transplantation : Twenty-eighth Adult Heart Transplant Report-2011. J Heart Lung Transplant 2011 ; 30 : 1078-1094
 
3) 福嶌教偉 : mTOR阻害剤-シロリムス, エベロリムス. 移植 2006 ; 41 : 305-311
 
4) Billingham, ME et al : A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection : Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990 ; 9 : 587-593
 
5) 日本移植学会ほか編 : ヒト移植臓器拒絶反応の病理組織診断基準, 鑑別診断と生検標本の取扱い (図譜), 腎臓移植, 肝臓移植, 膵臓移植, 心臓移植および肺移植, 第2版, 金原出版, 東京, 2009
 
6) Betkowski, AS et al : Panel-reactive antibody screening practices prior to heart transplantation. J Heart Lung Transplant 2002 ; 21 : 644-650
 
7) Stewart, S et al : Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005 ; 24 : 1710-1720
 
8) Baran, DA et al : Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab. Transplant Proc 2004 ; 36 : 3164-3166
 
9) Itescu, S et al : Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients. Circulation 2002 ; 105 : 1214-1219
 
P.207 掲載の参考文献
1) Miller, LW et al : Infection after heart transplantation : a multi institutional study. Cardiac Transplant Research Database Group. J Heart Lung Transplant 1994 ; 13 : 381-392
 
2) Costanzo, MR et al : The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010 ; 29 : 914-956
 
P.211 掲載の参考文献
1) Stehlik, J et al : The Registry of the International Society for Heart and Lung Transplantation : twenty-eighth adult heart transplant report(TM) 2011. J Heart Lung Transplant 2011 ; 30 : 1078-1194
 
2) Hosenpud, JD et al : Cardiac allograft vasculopathy : Current concepts, recent developments, and future directions. J Heart Lung Transplant 1992 ; 11 : 9-23
 
3) 布田伸一ほか : 心移植遠隔期における移植心冠動脈病変の検討. 脈管学 2001 ; 41 : 887-893
 
4) Kobashigawa, JA et al : Multicenter intravascular ultrasound validation study among heart transplant recipients : outcomes after five years. J Am Coll Cardiol 2005 ; 45 : 1532-1537
 
5) Nunoda, S et al : Evaluation of cardiac allograft vasculopathy by multidetector computed tomography and whole-heart magnetic resonance coronary angiography. Circ J 2010 ; 74 : 946-953
 
6) Eisen, HJ et al : Everolimus for the prevention of allograft rejection and vasculopathy in cardiactransplant recipients. N Engl J Med 2003 ; 349 : 847-858
 
7) Zuckermann, A et al : Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation. J Heart Lung Transplant 2008 ; 27 : 141-149
 
P.215 掲載の参考文献
1) Stehlik, J et al : The Registry of the International Society for Heart and Lung Transplantation : Twenty-eighth Adult Heart Transplant Report-2011. J Heart Lung Transplant 2011 ; 30 : 1078-1094
 
2) Opelz, G et al : Lymphomas after solid organ transplantation : a collaborative transplant study report. Am J Transplant 2004 ; 4 : 222-230
 
3) Savasta, M et al : Incidence of neoplastic disease in cardiac allograft recipients. Rev Cardiovasc Med 2011 ; 12 : 219-226
 
4) Parker, A et al : Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients-BCSH and BTS Guidelines. Br J Haematol 2010 ; 149 : 693-705
 
5) Oliveira, GH et al : Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation. J Heart Lung Transplant 2012 ; 31 : 805-810
 
P.220 掲載の参考文献
1) Tsuji, H et al : Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 2010 ; 106 : 1613-1623
 
2) Bolli, R et al : Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO) : initial results of a randomised phase 1 trial. Lancet 2011 ; 378 : 1847-1857
 
3) Takehara, N et al : Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol 2008 ; 52 : 1858-1865
 
4) Schwartz, SD et al : Embryonic stem cell trials for macular degeneration : a preliminary report. Lancet 2012 ; 379 : 713-720
 
5) Qian, L et al : In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012 ; 485 : 593-598
 
P.224 掲載の参考文献
1) Kimura, T et al : Safety and efficacy of pericardial endoscopy by percutaneous subxyphoid approach in swine heart in vivo. J Thorac Cardiovasc Surg 2011 ; 142 : 181-190
 
2) Chachques, JC et al : Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial) : Clinical Feasibility Study. Ann Thorac Surg 2008 ; 85 : 901-908
 
3) Sawa, Y et al : Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM : report of a case. Surg Today 2012 ; 42 : 181-184
 
4) Itabashi, Y et al : Analysis of the electrophysiological properties and arrhythmias in directly contacted skeletal and cardiac muscle cell sheets. Cardiovasc Res 2005 ; 67 : 561-570
 
5) Suzuki, R et al : Omentopexy enhances graft function in myocardial cell sheet transplantation. Biochem Biophys Res Commun 2009 ; 387 : 353-359
 
P.234 掲載の参考文献
1) Klotz, S et al : Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog Biophys Mol Biol 2008 ; 97 : 479-496
 
2) Drakos, SG et al : Left ventricular assist device unloading effects on myocardial structure and function : current status of the field and call for action. Curr Opin Cardiol 2011 ; 26 : 245-255
 
3) Dandel, M et al : Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy : criteria for weaning from ventricular assist devices. Eur Heart J 2011 ; 32 : 1148-1160
 
4) Santelices, LC et al : Development of a hybrid decision support model for optimal ventricular assist device weaning. Ann Thorac Surg 2010 ; 90 : 713-720
 
5) Birks, EJ et al : Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy : a prospective study. Circulation 2011 ; 123 : 381-390
 
6) Gojo. S et al : Cardiac resurrection after bone-marrow-derived mononuclear cell transplantation during left ventricular assist device support. Ann Thorac Surg 2007 ; 83 : 661-662
 
7) Siu, CW et al : Cardiac regeneration : messages from CADUCEUS. Lancet 2012 ; 379 : 870-871
 

[VI] 在宅安全管理のKnack & Pitfalls

P.240 掲載の参考文献
1) Kirklin, JK et al : Second INTERMACS annual report : more than 1, 000 primary left ventricular assist device implants. J Heart Lung Transplant 2010 ; 29 : 1-10
 
2) Kormos, RL et al : Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device : Incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010 ; 139 : 1316-1324
 
3) Pagani, FD et al : Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009 ; 54 : 312-321
 
P.244 掲載の参考文献
1) 遠藤美代子ほか : 補助人工心臓の管理とケア, 重症心不全患者の治療とケア, 心不全ケア教本, 真茅まゆみほか編, メディカル・サイエンス・インターナショナル, 東京, 2012, 227-251
 
2) 遠藤美代子ほか : LVAD装着後の自宅復帰プログラム (第13回重症心不全治療フォーラム). 呼吸と循環 2011 ; 59 : S 24-S 26
 
3) 遠藤美代子ほか : 心臓外科看護の知識と実際, 上田裕一編著, メディカ出版, 大阪, 2009, 307-320
 
P.248 掲載の参考文献
1) 百瀬直樹ほか : Toyobo 補助人工心臓 (VAS) における長期管理の工夫. 人工臓器 2007 ; 36 : 142-144
 
P.252 掲載の参考文献
1) Slaughter, MS : Hematologic effects of continuous flow left ventricular assist devices. J Cardiovasc Transl Res 2010 ; 3 : 618-624
 
2) Crow, S et al : Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009 ; 137 : 208-215
 
3) Morshuis, M et al : DuraHeart (TM) magnetically levitated centrifugal left ventricular assist system for advanced heart failure patients. Expert Rev Med Devices 2010 ; 7 : 173-183
 
4) Slaughter, MS et al : Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010 ; 29 (4 Suppl) : S 1-S 39
 

書評

最近チェックした商品履歴

Loading...